Treatment of HF in an Era of Multiple Therapies is a research paper published in JACC Heart Failure (2020). On theSindex it has a DataRank of 1.6. It has been cited 36 times, with 27 citing works in its 1-hop citation network.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.542
From this paper's citation signal
Citation Network Contribution
1.1
From 20 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 27 citers.
National Heart, Lung, and Blood Institute
Grant: T32HL094301
FDA HHS
Grant: R18 FD006920
Cytokinetics
Merck
Medtronic
Amgen
Bayer Fund
Bristol-Myers Squibb
MyoKardia
National Center for Advancing Translational Sciences
National Institutes of Health
Novartis
Abbott Laboratories
Edwards Lifesciences
U.S. Food and Drug Administration
AstraZeneca
American Heart Association
Gilead Sciences
GlaxoSmithKline
Boehringer Ingelheim
FWCI
3.71
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords